Registered number
12096987
Studio C Treatments Limited
Filleted Accounts
31 July 2025
Studio C Treatments Limited
Registered number: 12096987
Balance Sheet
as at 31 July 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 1,513 1,222
Current assets
Stocks 1,222 1,100
Debtors 4 100,000 100,000
Cash at bank and in hand 55,973 53,780
157,195 154,880
Creditors: amounts falling due within one year 5 (105,207) (120,564)
Net current assets 51,988 34,316
Net assets 53,501 35,538
Capital and reserves
Called up share capital 100 100
Profit and loss account 53,401 35,438
Shareholder's funds 53,501 35,538
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
C Vaughan
Director
Approved by the board on 22 April 2026
Studio C Treatments Limited
Notes to the Accounts
for the year ended 31 July 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Office Equipment
£
Cost
At 1 August 2024 1,629
Additions 795
At 31 July 2025 2,424
Depreciation
At 1 August 2024 407
Charge for the year 504
At 31 July 2025 911
Net book value
At 31 July 2025 1,513
At 31 July 2024 1,222
4 Debtors 2025 2024
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 100,000 100,000
5 Creditors: amounts falling due within one year 2025 2024
£ £
Taxation and social security costs 4,962 2,589
Other creditors 100,245 117,975
105,207 120,564
6 Controlling party
The company is controlled by C Tropea on the basis that she holds 100% of the ordinary issued share capital of the company.
7 Other information
Studio C Treatments Limited is a private company limited by shares and incorporated in England. Its registered office is:
Pennyweights
Kenley
CR8 5HB
Studio C Treatments Limited 12096987 false 2024-08-01 2025-07-31 2025-07-31 VT Final Accounts February 2026 C Vaughan No description of principal activity 12096987 2023-08-01 2024-07-31 12096987 core:WithinOneYear 2024-07-31 12096987 core:ShareCapital 2024-07-31 12096987 core:RetainedEarningsAccumulatedLosses 2024-07-31 12096987 2024-08-01 2025-07-31 12096987 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12096987 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 12096987 bus:Director40 2024-08-01 2025-07-31 12096987 2 2024-08-01 2025-07-31 12096987 core:PlantMachinery 2024-08-01 2025-07-31 12096987 countries:England 2024-08-01 2025-07-31 12096987 bus:FRS102 2024-08-01 2025-07-31 12096987 bus:FilletedAccounts 2024-08-01 2025-07-31 12096987 2025-07-31 12096987 core:WithinOneYear 2025-07-31 12096987 core:ShareCapital 2025-07-31 12096987 core:RetainedEarningsAccumulatedLosses 2025-07-31 12096987 core:PlantMachinery 2025-07-31 12096987 2024-07-31 12096987 core:PlantMachinery 2024-07-31 iso4217:GBP xbrli:pure